Skip to main content
SpringerLink
Log in

KSHV-Associated Disease in the AIDS Patient

  • Chapter
Aids-Associated Viral Oncogenesis

Part of the book series: Cancer Treatment and Research ((CTAR,volume 133))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kaposi, M. 1872. Idiopatisches multiples Pigmentsarkom der Haut. Arch Dermatol Syphillis 4:265–73.

    Article  Google Scholar 

  2. Chang, Y., E. Cesarman, M. S. Pessin, et al. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266(5192):1865–9.

    Article  PubMed  CAS  Google Scholar 

  3. Martin, J. N., D. E. Ganem, D. H. Osmond, et al. 1998. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338(14):948–54.

    Article  PubMed  CAS  Google Scholar 

  4. Mbulaiteye, S. M., R. J. Biggar, J. J. Goedert, et al. 2003. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 32(5):527–33.

    Article  PubMed  Google Scholar 

  5. Civati, G., G. Busnach, B. Brando, et al. 1988. Occurrence of Kaposi's sarcoma in renal transplant recipients treated with low doses of cyclosporine. Transplant Proc 20(Suppl 3):924–8.

    PubMed  CAS  Google Scholar 

  6. Mendez, J. C., G. W. Procop, M. J. Espy, et al. 1999. Relationship of HHV8 replication and Kaposi's sarcoma after solid organ trasplantation. Transplantation 67(8):1200–1.

    Article  PubMed  CAS  Google Scholar 

  7. Barozzi, P., M. Luppi, F. Facchetti, et al. 2003. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med 9(5):554–61.

    Article  PubMed  CAS  Google Scholar 

  8. Stallone, G., A. Schena, B. Infante, et al. 2005. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352(13):1317–23.

    Article  PubMed  CAS  Google Scholar 

  9. Gao, S. J., L. Kingsley, D. R. Hoover, et al. 1996. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 335(4):233–41.

    Article  PubMed  CAS  Google Scholar 

  10. Dupin, N., M. Grandadam, V. Calvez, et al. 1995. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 345(8952):761–2.

    Article  PubMed  CAS  Google Scholar 

  11. Hong, Y. K., K. Foreman, J. W. Shin, et al. 2004. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36(7):683–5.

    Article  PubMed  CAS  Google Scholar 

  12. Wang, H. W., M. W. Trotter, D. Lagos, et al. 2004. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36(7):687–93.

    Article  PubMed  CAS  Google Scholar 

  13. Kaaya, S. F., M. T. Leshabari, and J. K. Mbwambo. 1998. Risk behaviors and vulnerability to HIV infection among Tanzanian youth. J Health Popul Dev Ctries 1(2):51–60.

    PubMed  CAS  Google Scholar 

  14. Rabkin, C. S., S. Janz, A. Lash, et al. 1997. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 336(14):988–93.

    Article  PubMed  CAS  Google Scholar 

  15. Whitby, D., M. R. Howard, M. Tenant-Flowers, et al. 1995. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346(8978):799–802.

    Article  PubMed  CAS  Google Scholar 

  16. Pellet, C., D. Kerob, A. Dupuy, et al. 2006. Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma. J Invest Dermatol 126(3):621–7.

    Article  PubMed  CAS  Google Scholar 

  17. Decker, L. L., P. Shankar, G. Khan, et al. 1996. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 184(1):283–8.

    Article  PubMed  CAS  Google Scholar 

  18. Staskus, K. A., W. Zhong, K. Gebhard, et al. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71(1):715–9.

    PubMed  CAS  Google Scholar 

  19. Rappocciolo, G., F. J. Jenkins, H. R. Hensler, et al. 2006. DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol 176(3):1741–9.

    PubMed  CAS  Google Scholar 

  20. Lagunoff, M., J. Bechtel, E. Venetsanakos, et al. 2002. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J Virol 76(5):2440–8.

    Article  PubMed  CAS  Google Scholar 

  21. Grundhoff, A., and D. Ganem. 2004. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113(1):124–36.

    PubMed  CAS  Google Scholar 

  22. An, F. Q., H. M. Folarin, N. Compitello, et al. 2006. Long-term-infected telomerase-immortalized endothelial cells: A model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo. J Virol 80(10):4833–46.

    Article  PubMed  CAS  Google Scholar 

  23. De Rosa, G., E. Barra, M. Guarino, et al. 1989. Multicentric Castleman's disease in association with Kaposi's sarcoma. Appl Pathol 7(2):105–10.

    PubMed  Google Scholar 

  24. Farge, D., C. Lebbe, Z. Marjanovic, et al. 1999. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF). Transplantation 67(9):1236–42.

    Article  PubMed  CAS  Google Scholar 

  25. Cesarman, E., Y. Chang, P. S. Moore, et al. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332(18):1186–91.

    Article  PubMed  CAS  Google Scholar 

  26. Soulier, J., L. Grollet, E. Oksenhendler, et al. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86(4):1276–80.

    PubMed  CAS  Google Scholar 

  27. Parravicini, C., B. Chandran, M. Corbellino, et al. 2000. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 156(3):743–9.

    PubMed  CAS  Google Scholar 

  28. Du, M. Q., H. Liu, T. C. Diss, et al. 2001. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97(7):2130–6.

    Article  PubMed  CAS  Google Scholar 

  29. Ablashi, D. V., L. G. Chatlynne, J. E. Whitman, Jr., et al. 2002. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15(3):439–64.

    Article  PubMed  Google Scholar 

  30. Nador, R. G., E. Cesarman, A. Chadburn, et al. 1996. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88(2):645–56.

    PubMed  CAS  Google Scholar 

  31. Du, M. Q., T. C. Diss, H. Liu, et al. 2002. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood 100(9):3415–8.

    Article  PubMed  CAS  Google Scholar 

  32. Deloose, S. T., L. A. Smit, F. T. Pals, et al. 2005. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 19(5):851–5.

    Article  PubMed  CAS  Google Scholar 

  33. Carbone, A., A. Gloghini, E. Vaccher, et al. 2005. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma. J Mol Diagn 7(1):17–27.

    PubMed  CAS  Google Scholar 

  34. Kedes, D. H., E. Operskalski, M. Busch, et al. 1996. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2(8):918–24.

    Article  PubMed  CAS  Google Scholar 

  35. Whitby, D., M. Luppi, P. Barozzi, et al. 1998. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 90(5):395–7.

    Article  PubMed  CAS  Google Scholar 

  36. Vieira, J., M. L. Huang, D. M. Koelle, et al. 1997. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 71(9):7083–7.

    PubMed  CAS  Google Scholar 

  37. Brayfield, B. P., C. Kankasa, J. T. West, et al. 2004. Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission. J Infect Dis 189(12):2260–70.

    Article  PubMed  Google Scholar 

  38. Damania, B. 2004. Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis. Nat Rev Microbiol 2(8):656–68.

    Article  PubMed  CAS  Google Scholar 

  39. Russo, J. J., R. A. Bohenzky, M. C. Chien, et al. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93(25):14862–7.

    Article  PubMed  CAS  Google Scholar 

  40. Fakhari, F. D., and D. P. Dittmer. 2002. Charting latency transcripts in Kaposi's sarcoma-assocaited herpesvirus by whole-genome real-time quantitative reverse transcription-PCR. J Virol 76(12):6213–23.

    Article  PubMed  CAS  Google Scholar 

  41. Dittmer, D. P. 2003. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res 63(9):2010–5.

    PubMed  CAS  Google Scholar 

  42. Jenner, R. G., M. M. Alba, C. Boshoff, et al. 2001. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75(2):891–902.

    Article  PubMed  CAS  Google Scholar 

  43. Paulose-Murphy, M., N. K. Ha, C. Xiang, et al. 2001. Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). J Virol 75(10):4843–53.

    Article  PubMed  CAS  Google Scholar 

  44. Jenner, R. G., K. Maillard, N. Cattini, et al. 2003. Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci USA 100(18): 10399–404.

    Article  PubMed  CAS  Google Scholar 

  45. Klein, U., A. Gloghini, G. Gaidano, et al. 2003. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101(10):4115–21.

    Article  PubMed  CAS  Google Scholar 

  46. Fan, W., D. Bubman, A. Chadburn, et al. 2005. Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J Virol 79(2):1244–51.

    Article  PubMed  CAS  Google Scholar 

  47. Poole, L. J., Y. Yu, P. S. Kim, et al. 2002. Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus. J Virol 76(7):3395–420.

    Article  PubMed  CAS  Google Scholar 

  48. Naranatt, P. P., H. H. Krishnan, S. R. Svojanovsky, et al. 2004. Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res 64(1):72–84.

    Article  PubMed  CAS  Google Scholar 

  49. Moses, A. V., M. A. Jarvis, C. Raggo, et al. 2002. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J Virol 76(16):8383–99.

    Article  PubMed  CAS  Google Scholar 

  50. Renne, R., C. Barry, D. Dittmer, et al. 2001. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus [In Process Citation]. J Virol 75(1):458–68.

    Article  PubMed  CAS  Google Scholar 

  51. Koon, H. B., G. J. Bubley, L. Pantanowitz, et al. 2005. Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J Clin Oncol 23(5):982–9.

    Article  PubMed  CAS  Google Scholar 

  52. Dezube, B. J., S. E. Krown, J. Y. Lee, et al. 2006. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol 24(9):1389–94.

    Article  PubMed  CAS  Google Scholar 

  53. Dittmer, D., M. Lagunoff, R. Renne, et al. 1998. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72(10):8309–15.

    PubMed  CAS  Google Scholar 

  54. Dupin, N., C. Fisher, P. Kellam, et al. 1999. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96(8):4546–51.

    Article  PubMed  CAS  Google Scholar 

  55. Li, H., T. Komatsu, B. J. Dezube, et al. 2002. The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol 76(23):11880–8.

    Article  PubMed  CAS  Google Scholar 

  56. Sadler, R., L. Wu, B. Forghani, et al. 1999. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol 73(7):5722–30.

    PubMed  CAS  Google Scholar 

  57. McCormick, C., and D. Ganem. 2005. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307(5710):739–41.

    Article  PubMed  CAS  Google Scholar 

  58. Staudt, M. R., Y. Kanan, J. H. Jeong, et al. 2004. The tumor microenvironment controls primary effusion lymphoma growth in vivo. Cancer Res 64(14):4790–9.

    Article  PubMed  CAS  Google Scholar 

  59. Wang, L., D. P. Dittmer, C. C. Tomlinson, et al. 2006. Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res 66(7):3658–66.

    Article  PubMed  CAS  Google Scholar 

  60. Wang, L., N. Wakisaka, C. C. Tomlinson, S. DeWire, S. Krall, J. S. Pagano, and B. Damania. 2004. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 64:2774–81.

    Article  PubMed  CAS  Google Scholar 

  61. Moore, P. S., L. A. Kingsley, S. D. Holmberg, et al. 1996. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. Aids 10(2):175–80.

    Article  PubMed  CAS  Google Scholar 

  62. Bais, C., A. Van Geelen, P. Eroles, et al. 2003. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR. Cancer Cell 3(2):131–43.

    Article  PubMed  CAS  Google Scholar 

  63. Montaner, S., A. Sodhi, A. Molinolo, et al. 2003. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3(1):23–36.

    Article  PubMed  CAS  Google Scholar 

  64. Rivas, C., A. E. Thlick, C. Parravicini, et al. 2001. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53 [In Process Citation]. J Virol 75(1):429–38.

    Article  PubMed  CAS  Google Scholar 

  65. Northfelt, D. W., B. J. Dezube, J. A. Thommes, et al. 1998. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 16(7):2445–51.

    PubMed  CAS  Google Scholar 

  66. Noy, A., D. T. Scadden, J. Lee, et al. 2005. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. J Clin Oncol 23(5):990–8.

    Article  PubMed  CAS  Google Scholar 

  67. Klass, C. M., L. T. Krug, V. P. Pozharskaya, et al. 2005. The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production. Blood 105(10):4028–34.

    Article  PubMed  CAS  Google Scholar 

  68. Little, R. F., J. M. Pluda, K. M. Wyvill, et al. 2006. Activity of subcutaneous interleukin-12 in AIDS-related Kaposi's sarcoma. Blood 107(12):4650–7.

    Article  PubMed  CAS  Google Scholar 

  69. Clifford, G. M., J. Polesel, M. Rickenbach, et al. 2005. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97(6):425–32.

    Article  PubMed  Google Scholar 

  70. Ratner, L., J. Lee, S. Tang, et al. 2001. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19(8):2171–8.

    PubMed  CAS  Google Scholar 

  71. Scott, D., L. Cabral, W. J. Harrington, Jr. 2001. Treatment of HIV-associated multicentric Castleman's disease with oral etoposide. Am J Hematol 66(2):148–50.

    Article  PubMed  CAS  Google Scholar 

  72. Kaplan, L. D., J. Y. Lee, R. F. Ambinder, et al. 2005. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood 106(5):1538–43.

    Article  PubMed  CAS  Google Scholar 

  73. Ghosh, S. K., C. Wood, L. H. Boise, et al. 2003. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood 101(6):2321–7.

    Article  PubMed  CAS  Google Scholar 

  74. Casper, C., W. G. Nichols, M. L. Huang, et al. 2004. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 103(5):1632–4.

    Article  PubMed  CAS  Google Scholar 

  75. Martin, D. F., B. D. Kuppermann, R. A. Wolitz, et al. 1999. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 340(14):1063–70.

    Article  PubMed  CAS  Google Scholar 

  76. Little, R. F., F. Merced-Galindez, K. Staskus, et al. 2003. A pilot study of cidofovir in patients with kaposi sarcoma. J Infect Dis 187(1):149–53.

    Article  PubMed  CAS  Google Scholar 

  77. Sgadari, C., G. Barillari, E. Toschi, et al. 2002. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat Med 8(3):225–32.

    Article  PubMed  CAS  Google Scholar 

  78. Wong E. L., B. Damania. 2005. Linking KSHV to human cancer. Curr Oncol Rep 7(5):349–356.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology & Immunology & Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC

    Dirk P. Dittmer

  2. Department of Microbiology & Immunology & Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC

    Blossom Damania

Authors
  1. Dirk P. Dittmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Blossom Damania
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

C. Meyers

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Dittmer, D.P., Damania, B. (2007). KSHV-Associated Disease in the AIDS Patient. In: Meyers, C. (eds) Aids-Associated Viral Oncogenesis. Cancer Treatment and Research, vol 133. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-46816-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-46816-7_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-46804-4

  • Online ISBN: 978-0-387-46816-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation